Manganese decreases glutamate uptake in cultured astrocytes.
Recent data have shown an accumulation of manganese in the basal ganglia in patients with chronic hepatic encephalopathy (HE). Astrocytes and ammonia are critically involved in the pathogenesis of HE, and we have recently demonstrated that ammonia decreases glutamate uptake in cultured astrocytes. Since failure by astrocytes to take up glutamate may represent an important pathogenetic mechanism in HE, we, therefore, examined the effect of manganese on glutamate transport in these cells. Treatment of cultured astrocytes with 100 microM manganese for 2 days resulted in a 54% decrease in the uptake of D-aspartate, a nonmetabolizable analogue of glutamate. Kinetic analysis revealed a 28% decline in Vmax, with no change in the K(m). Treatment of cultures with 5 mM NH4 Cl inhibited D-aspartate uptake by 21%, and a combination of 5 mM NH4Cl with 100 microM manganese produced an additive effect on uptake inhibition. These results suggest a pathogenetic role for manganese in HE, possibly involving glutamate transport.
Hazell
A S
AS
Laboratory of Neuropathology, Veterans Administration Medical Center, Miami, Florida 33125, USA.
Norenberg
M D
MD
D000255:Adenosine Triphosphate / Q000378:metabolism; D000641:Ammonia / Q000494:pharmacology; D000818:Animals; D001224:Aspartic Acid / Q000187:drug effects / Q000378:metabolism; D001253:Astrocytes / Q000166:cytology / Q000187:drug effects*; D001692:Biological Transport / Q000187:drug effects; D002478:Cells, Cultured; D004338:Drug Combinations; D018698:Glutamic Acid / Q000187:drug effects* / Q000378:metabolism; D007700:Kinetics; D008345:Manganese / Q000494:pharmacology*; D051381:Rats; D013395:Sucrose / Q000378:metabolism
D004338:Drug Combinations; D001224:Aspartic Acid; D018698:Glutamic Acid; D008345:Manganese; D013395:Sucrose; D000641:Ammonia; D000255:Adenosine Triphosphate